| Shenzhen Kangtai Biological Products | |||||||||
| Type: | Public | ||||||||
| Predecessors: | --> | ||||||||
| Founder: | Du Weimin | ||||||||
| Successors: | --> | ||||||||
| Hq Location: | 6 Kefa Road, Science and Technology Park, Nanshan District, Shenzhen | ||||||||
| Hq Location City: | Shenzhen | ||||||||
| Hq Location Country: | China | ||||||||
| Areas Served: | --> | ||||||||
| Owners: | --> | ||||||||
| Num Employees: | 2043 | ||||||||
| Module: |
| ||||||||
Shenzhen Kangtai Biological Products, also known as BioKangtai, is a Chinese biopharmaceutical company that develops, manufactures and markets vaccines and other vaccine products.[1]
Kangtai develops the Minhai COVID-19 vaccine and has the exclusive right to manufacture the Oxford–AstraZeneca COVID-19 vaccine in mainland China.[2] [3] [4]